Literature DB >> 23241670

Expression in non-melanogenic systems and purification of soluble variants of human tyrosinase.

Petra Cordes1, Wei Sun, Rainer Wolber, Ludger Kolbe, Gerhard Klebe, Klaus-Heinrich Röhm.   

Abstract

Mammalian tyrosinases are key enzymes of melanin formation. Their native forms undergo complex maturation and sorting processes before being integrated into the melanosomal membrane, which greatly complicates their heterologous expression in other cell types. In the present work, we constructed several differently truncated, soluble variants of human tyrosinase and studied their properties after expression in HEK 293 cells. In addition, we prepared two affinity-tagged forms of the enzyme for expression in the yeast Kluyveromyces lactis and HEK cells, respectively. A Strep-tagged variant was secreted by K. lactis in excellent yields but found to be inactive, whereas a His-tagged variant secreted by HEK 293 cells in an active state could be purified from cell supernatants to near homogeneity. The resulting preparation consisted of an inactive, probably unglycosylated species of about 57 kDa and several glycosylated forms with masses between 63 and 75 kDa, as confirmed by activity staining, Western blotting and mass spectrometry.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23241670     DOI: 10.1515/hsz-2012-0300

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  3 in total

1.  Effective reduction of post-inflammatory hyperpigmentation with the tyrosinase inhibitor isobutylamido-thiazolyl-resorcinol (Thiamidol).

Authors:  Dennis Roggenkamp; Ncoza Dlova; Tobias Mann; Jan Batzer; Julia Riedel; Martina Kausch; Ivica Zoric; Ludger Kolbe
Journal:  Int J Cosmet Sci       Date:  2021-05-05       Impact factor: 2.970

2.  Structure-Activity Relationships of Thiazolyl Resorcinols, Potent and Selective Inhibitors of Human Tyrosinase.

Authors:  Tobias Mann; Cathrin Scherner; Klaus-Heinrich Röhm; Ludger Kolbe
Journal:  Int J Mol Sci       Date:  2018-02-28       Impact factor: 5.923

3.  Thiamidol containing treatment regimens in facial hyperpigmentation: An international multi-centre approach consisting of a double-blind, controlled, split-face study and of an open-label, real-world study.

Authors:  W G Philipp-Dormston; A Vila Echagüe; S H Pérez Damonte; J Riedel; A Filbry; K Warnke; C Lofrano; D Roggenkamp; G Nippel
Journal:  Int J Cosmet Sci       Date:  2020-08       Impact factor: 2.970

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.